Navigation Links
Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Date:12/18/2007

- PAH Pathways(TM) Program offers Patient Support and Financial Assistance

-

SOUTH SAN FRANCISCO, Calif., Dec. 18 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc. today announced results of a recent Harris Interactive(R) survey, showing that an overwhelming majority of Tracleer patients enrolled in Sure Steps find the patient support program valuable, and feel that their knowledge of pulmonary arterial hypertension (PAH) and Tracleer have improved due to the program. The Sure Steps program, part of Actelion's PAH Pathways(TM) service and support program, is a support and education program available to all PAH patients on Actelion's PAH products, Tracleer and Ventavis(R) (iloprost) Inhalation Solution.
Key findings from the survey of patients enrolled in Sure Steps show that:

-- Nine in ten (89 percent) enrolled patients are satisfied with the

program;

-- Almost all (97 percent) would recommend the program to other PAH

patients on Tracleer;

-- Six out of seven (85 percent) enrolled patients are more comfortable

discussing their PAH therapy with their physicians because of the

program; and

-- 92 percent feel better informed about Tracleer as a result of

information provided in the program.

The survey was conducted by Harris Interactive on behalf of Actelion between August 7 and August 21, 2007. It included more than 600 patients currently enrolled in Sure Steps, 256 of whom who had been on Tracleer for less than one year, and 354 patients who had been on Tracleer for more than a year. All patients were 18 year of age or older, diagnosed with PAH, currently taking Tracleer, and had been enrolled in the Sure Steps program for at least two months.

"When patients are first diagnosed with PAH and begin treatment, they are often overwhelmed by their diagnosis and have many questions about treatment," said Craig Hopkinson, MD, Vice
'/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... 9 Ardea Biosciences, Inc. (Nasdaq: ... , Ph.D., has been appointed to the Company,s Board ... Baker Bros. Advisors, LLC, the manager and advisor to ... ,, "Ardea,s impressive accomplishments have made it an ... to join the Board of Directors," commented Dr. Baker. ...
(Date:2/9/2010)... A leading clinical research center in ... study an investigational drug designed as a possible treatment ... affects between 45 and 90 percent of women of ... not life threatening, dysmenorrhea can be debilitating and psychologically ... absenteeism from work and school. ,, Current therapies for ...
(Date:2/9/2010)... Md. , Feb. 9 ... today that it will release its fourth quarter ... on Tuesday, February 16, 2010 . ,, ... Tuesday, February 16, 2010 , at ... accessible by dialing 1-888-695-0608, with international callers dialing ...
(Date:2/9/2010)... Feb. 9 The American Psychiatric ... sole medical education partner to prepare and manage ... meeting in New Orleans, Louisiana , from ... Enterprise will manage all elements of industry-supported symposia ... partnership with the APA. ,, "It is ...
Breaking Biology Technology:Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors 2Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors 3Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps 2CME Enterprise Named to Manage All Industry-Supported Symposia at 2010 APA Annual Meeting 2
... Call and Webcast Scheduled for Tuesday, February 5, ... NBIX ) announced today that the Company will report ... Nasdaq market closes,on Tuesday, February 5, 2008. Neurocrine will ... its financial results and provide a Company,update Tuesday afternoon, ...
... the biostability company,that offers innovative technologies for stabilizing ... preserving RNA at room,temperature, eliminating the need for ... has skyrocketed over the past years due to ... expression studies. However, RNA samples are,difficult to work ...
... 24 Aton Pharma, Inc., a,global ... it has,launched an expanded, comprehensive distribution ... patient education resources, for the,dry eye ... is a unique preservative-free, once-daily*, sustained,release ...
Other Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results 2Biomatrica's RNAstable(TM) Stabilizes RNA at Room Temperature 2Biomatrica's RNAstable(TM) Stabilizes RNA at Room Temperature 3Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye 2Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye 3
(Date:2/7/2010)... beer is a significant source of dietary silicon, a ... the Department of Food Science & Technology at the ... determine the relationship between beer production methods and the ... source of dietary silicon. Details of this study ... Journal of the Science of Food and Agriculture , ...
(Date:2/7/2010)... ST. PAUL, Minn. Workers exposed to tricholorethylene (TCE), ... as auto parts, may be at a significantly higher ... released today that will be presented at the American ... 10 to April 17, 2010. , "This is the ... that exposure to TCE may increase a person,s risk ...
(Date:2/7/2010)... announced today (7 Feb) they have identified for the ... humans. The team analyzed more than 500,000 genetic variations ... which are located near a gene called TERC. ... today by researchers from the University of Leicester and ... the Netherlands, was funded by The Wellcome Trust and ...
Breaking Biology News(10 mins):Research reveals link between beer and bone health 2Scientists identify first genetic variant linked to biological aging in humans 2Its Black Friday Time to Shop Off the Calories 21 Allrecipes Finds Average Thanksgiving Meal Weighed in at 2 225 Calories 62186 1Its Black Friday Time to Shop Off the Calories 21 Allrecipes Finds Average Thanksgiving Meal Weighed in at 2 225 Calories 62186 2Its Black Friday Time to Shop Off the Calories 21 Allrecipes Finds Average Thanksgiving Meal Weighed in at 2 225 Calories 62186 3Voyant Health Announces 3A Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 62185 1Voyant Health Announces 3A Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 62185 2Voyant Health Announces 3A Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 62185 3Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 1Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 2Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 3Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 4Clemente 26apos 3Bs Anatomy Rohen 26apos 3Bs Photographic Anatomy and Moore 26apos 3Bs Clinical Anatomy Customizable Apps Now Available on App Store 62182 5
... SVOX, the leading provider of,embedded speech solutions today ... of Siemens AG, according to SVOX CEO Volker ... Siemens AG developed,over 25 years, including the SpeechAdvance(TM) ... families. The majority of the Professional,Speech Processing Group,s ...
... people know that too much sodium from foods can increase ... to lower their blood pressure should also boost their intake ... Researchers found that the ratio of sodium-to-potassium in subjects, urine ... or potassium alone. , "There isn,t as much focus ...
... Science Foundation and the U.S. Implementing Organization for the ... the research vessel JOIDES Resolution sailing off from Singapore ... a complete transformation to modernize and upgrade the ship ... is the U.S. research vessel for exploring and monitoring ...
Other Biology News:SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2Cutting salt isn't the only way to reduce blood pressure 2Ocean research officials hail completion of modernization for US scientific ocean drilling vessel 2
...
...
... allow for the rapid isolation of DNA from ... slice in the spin filter, centrifuge for 3 ... recovered. There is no need to melt agarose ... can also be used for buffer exchange, primer ...
ChemiArray Human Cytokine Antibody Array VII, 60 cytokines per membrane...
Biology Products: